Domača stranBAX • VIE
add
Baxter International
Prejšnji trg. dan.
17,54 €
Dnevni razpon
17,03 € - 17,30 €
Letni razpon
15,06 € - 34,60 €
Tržna kapitalizacija
10,48 mrd. USD
Povprečni obseg
139,00
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
NYSE
V novicah
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 2,97 mrd. | 8,03 % |
Stroški poslovanja | 741,00 mio. | −13,13 % |
Čisti dohodek | −1,13 mrd. | −120,31 % |
Čista dobičkovnost prihodkov | −37,93 | −103,92 % |
Earnings per share | 0,44 | −24,14 % |
EBITDA | 459,00 mio. | −10,87 % |
Efektivna davčna stopnja | −36,90 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 1,97 mrd. | 11,45 % |
Skupna sredstva | 20,06 mrd. | −22,21 % |
Skupne obveznosti | 13,95 mrd. | −25,62 % |
Celoten lastniški kapital | 6,10 mrd. | — |
Shares outstanding | 514,49 mio. | — |
Razmerje P/B | 1,47 | — |
Donosnost sredstev | 2,66 % | — |
Donosnost kapitala | 3,34 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | dec. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −1,13 mrd. | −120,31 % |
Denar iz dejavnosti | 584,00 mio. | 19,67 % |
Denar iz naložb | −198,00 mio. | 3,41 % |
Denar iz financiranja | −147,00 mio. | −204,26 % |
Neto sprememba denarnih sredstev | 240,00 mio. | −28,14 % |
Prost denarni tok | 397,75 mio. | −32,04 % |
Vizitka
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
Generalni direktor
Datum ustanovitve
1931
Sedež organizacije
Spletno mesto
Zaposleni
37.500
